FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136363970> ?p ?o ?g. }

• W3136363970 abstract "Abstract There is increasing evidence that the core clock gene Period 1 (PER1) plays important roles in the formation of various tumors. However, the biological functions and mechanism of PER1 in promoting tumor progression remain largely unknown. Here, we discovered that PER1 was markedly downregulated in oral squamous cell carcinoma (OSCC). Then, OSCC cell lines with stable overexpression, knockdown, and mutation of PER1 were established. We found that PER1 overexpression significantly inhibited glycolysis, glucose uptake, proliferation, and the PI3K/AKT pathway in OSCC cells. The opposite effects were observed in PER1-knockdown OSCC cells. After treatment of PER1-overexpressing OSCC cells with an AKT activator or treatment of PER1-knockdown OSCC cells with an AKT inhibitor, glycolysis, glucose uptake, and proliferation were markedly rescued. In addition, after treatment of PER1-knockdown OSCC cells with a glycolysis inhibitor, the increase in cell proliferation was significantly reversed. Further, coimmunoprecipitation (Co-IP) and cycloheximide (CHX) chase experiment demonstrated that PER1 can bind with RACK1 and PI3K to form the PER1/RACK1/PI3K complex in OSCC cells. In PER1-overexpressing OSCC cells, the abundance of the PER1/RACK1/PI3K complex was significantly increased, the half-life of PI3K was markedly decreased, and glycolysis, proliferation, and the PI3K/AKT pathway were significantly inhibited. However, these effects were markedly reversed in PER1-mutant OSCC cells. In vivo tumorigenicity assays confirmed that PER1 overexpression inhibited tumor growth while suppressing glycolysis, proliferation, and the PI3K/AKT pathway. Collectively, this study generated the novel findings that PER1 suppresses OSCC progression by inhibiting glycolysis-mediated cell proliferation via the formation of the PER1/RACK1/PI3K complex to regulate the stability of PI3K and the PI3K/AKT pathway-dependent manner and that PER1 could potentially be a valuable therapeutic target in OSCC." @default.
• W3136363970 created "2021-03-29" @default.
• W3136363970 creator A5032673983 @default.
• W3136363970 creator A5035913116 @default.
• W3136363970 creator A5053088432 @default.
• W3136363970 date "2021-03-15" @default.
• W3136363970 modified "2023-10-13" @default.
• W3136363970 title "PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex" @default.
• W3136363970 cites W1574675143 @default.
• W3136363970 cites W1976883959 @default.
• W3136363970 cites W2016670036 @default.
• W3136363970 cites W2041580366 @default.
• W3136363970 cites W2047621859 @default.
• W3136363970 cites W2071501137 @default.
• W3136363970 cites W2074740400 @default.
• W3136363970 cites W2081027705 @default.
• W3136363970 cites W2097259163 @default.
• W3136363970 cites W2122339465 @default.
• W3136363970 cites W2128490578 @default.
• W3136363970 cites W2129824771 @default.
• W3136363970 cites W2143210222 @default.
• W3136363970 cites W2234115940 @default.
• W3136363970 cites W2274859364 @default.
• W3136363970 cites W2332799968 @default.
• W3136363970 cites W2415148935 @default.
• W3136363970 cites W2460874475 @default.
• W3136363970 cites W2479222723 @default.
• W3136363970 cites W2487740014 @default.
• W3136363970 cites W2513840682 @default.
• W3136363970 cites W2535284666 @default.
• W3136363970 cites W2557860064 @default.
• W3136363970 cites W2567503091 @default.
• W3136363970 cites W2572086662 @default.
• W3136363970 cites W2752339148 @default.
• W3136363970 cites W2770522507 @default.
• W3136363970 cites W2792376822 @default.
• W3136363970 cites W2810235826 @default.
• W3136363970 cites W2810826647 @default.
• W3136363970 cites W2843374599 @default.
• W3136363970 cites W2889646458 @default.
• W3136363970 cites W2897204809 @default.
• W3136363970 cites W2900487160 @default.
• W3136363970 cites W2931898983 @default.
• W3136363970 cites W2950591923 @default.
• W3136363970 cites W2972439987 @default.
• W3136363970 cites W2980398814 @default.
• W3136363970 cites W2982401927 @default.
• W3136363970 cites W3007445926 @default.
• W3136363970 doi "https://doi.org/10.1038/s41419-021-03563-5" @default.
• W3136363970 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7960720" @default.
• W3136363970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33723221" @default.
• W3136363970 hasPublicationYear "2021" @default.
• W3136363970 type Work @default.
• W3136363970 sameAs 3136363970 @default.
• W3136363970 citedByCount "24" @default.
• W3136363970 countsByYear W31363639702021 @default.
• W3136363970 countsByYear W31363639702022 @default.
• W3136363970 countsByYear W31363639702023 @default.
• W3136363970 crossrefType "journal-article" @default.
• W3136363970 hasAuthorship W3136363970A5032673983 @default.
• W3136363970 hasAuthorship W3136363970A5035913116 @default.
• W3136363970 hasAuthorship W3136363970A5053088432 @default.
• W3136363970 hasBestOaLocation W31363639701 @default.
• W3136363970 hasConcept C104317684 @default.
• W3136363970 hasConcept C150194340 @default.
• W3136363970 hasConcept C173396325 @default.
• W3136363970 hasConcept C184738001 @default.
• W3136363970 hasConcept C185592680 @default.
• W3136363970 hasConcept C190283241 @default.
• W3136363970 hasConcept C2780360009 @default.
• W3136363970 hasConcept C502942594 @default.
• W3136363970 hasConcept C55493867 @default.
• W3136363970 hasConcept C62112901 @default.
• W3136363970 hasConcept C62478195 @default.
• W3136363970 hasConcept C75217442 @default.
• W3136363970 hasConcept C86554907 @default.
• W3136363970 hasConcept C86803240 @default.
• W3136363970 hasConcept C95444343 @default.
• W3136363970 hasConceptScore W3136363970C104317684 @default.
• W3136363970 hasConceptScore W3136363970C150194340 @default.
• W3136363970 hasConceptScore W3136363970C173396325 @default.
• W3136363970 hasConceptScore W3136363970C184738001 @default.
• W3136363970 hasConceptScore W3136363970C185592680 @default.
• W3136363970 hasConceptScore W3136363970C190283241 @default.
• W3136363970 hasConceptScore W3136363970C2780360009 @default.
• W3136363970 hasConceptScore W3136363970C502942594 @default.
• W3136363970 hasConceptScore W3136363970C55493867 @default.
• W3136363970 hasConceptScore W3136363970C62112901 @default.
• W3136363970 hasConceptScore W3136363970C62478195 @default.
• W3136363970 hasConceptScore W3136363970C75217442 @default.
• W3136363970 hasConceptScore W3136363970C86554907 @default.
• W3136363970 hasConceptScore W3136363970C86803240 @default.
• W3136363970 hasConceptScore W3136363970C95444343 @default.
• W3136363970 hasIssue "3" @default.
• W3136363970 hasLocation W31363639701 @default.
• W3136363970 hasLocation W31363639702 @default.
• W3136363970 hasLocation W31363639703 @default.
• W3136363970 hasOpenAccess W3136363970 @default.
• W3136363970 hasPrimaryLocation W31363639701 @default.
• W3136363970 hasRelatedWork W2278983970 @default.

• next